Labcorp Holdings Inc. (LH)
Healthcare • Diagnostics & Research
StockNYSEUnited StatesUS5049221055
372.32 USD
+0.02% today Updated 13 Nov 2026 14:05
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Labcorp Holdings Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 14:05. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
23 Feb 2027
in 102 days · 08:00 · estimate 4.51
Last results
4.78 vs 4.64 estimated
28 Oct 2026 · Beat +2.9%
Beat the estimate
11 of 12
0 missed · 1 in line · 8 beats in a row
Average surprise
+3.0%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 23 Feb 2027 08:00 | 4.51 | — | — | Upcoming |
| 28 Oct 2026 06:00 | 4.64 | 4.78 | +2.9% | Beat |
| 30 Jul 2026 06:00 | 4.77 | 4.99 | +4.7% | Beat |
| 30 Apr 2026 06:00 | 4.12 | 4.25 | +3.3% | Beat |
| 17 Feb 2026 06:00 | 3.94 | 4.07 | +3.3% | Beat |
| 28 Oct 2025 06:00 | 4.14 | 4.18 | +1.0% | Beat |
| 24 Jul 2025 06:00 | 4.16 | 4.35 | +4.5% | Beat |
| 29 Apr 2025 06:00 | 3.73 | 3.84 | +2.8% | Beat |
| 06 Feb 2025 06:00 | 3.39 | 3.45 | +1.7% | Beat |
| 24 Oct 2024 06:00 | 3.49 | 3.50 | +0.2% | In line |
| 01 Aug 2024 06:00 | 3.77 | 3.94 | +4.5% | Beat |
| 25 Apr 2024 06:00 | 3.48 | 3.68 | +5.7% | Beat |
| 15 Feb 2024 06:00 | 3.26 | 3.30 | +1.3% | Beat |
| 26 Oct 2023 06:00 | 3.33 | 3.38 | +1.5% | Beat |
| 27 Jul 2023 06:00 | 3.45 | 3.42 | -1.0% | In line |
| 25 Apr 2023 06:00 | 3.96 | 3.82 | -3.6% | Miss |
| 16 Feb 2023 07:00 | 4.14 | 4.14 | +0.1% | In line |
| 27 Oct 2022 07:00 | 4.68 | 4.68 | +0.0% | In line |
| 28 Jul 2022 07:00 | 4.68 | 4.96 | +5.9% | Beat |
| 28 Apr 2022 06:00 | 6.00 | 6.11 | +1.8% | Beat |
| 10 Feb 2022 07:00 | 6.00 | 6.77 | +12.9% | Beat |
| 28 Oct 2021 06:00 | 4.92 | 6.82 | +38.6% | Beat |
| 29 Jul 2021 07:00 | 5.62 | 6.13 | +9.0% | Beat |
| 29 Apr 2021 06:00 | 7.49 | 8.79 | +17.4% | Beat |
| 11 Feb 2021 06:00 | 8.07 | 10.56 | +30.9% | Beat |
| 27 Oct 2020 06:00 | 5.32 | 8.41 | +58.1% | Beat |
| 28 Jul 2020 06:00 | 0.99 | 2.57 | +158.8% | Beat |
| 29 Apr 2020 07:00 | 1.95 | 2.37 | +21.6% | Beat |
| 13 Feb 2020 06:00 | 2.80 | 2.86 | +2.1% | Beat |
| 24 Oct 2019 06:00 | 2.85 | 2.90 | +1.8% | Beat |
| 25 Jul 2019 07:00 | 2.92 | 2.93 | +0.3% | In line |
| 30 Apr 2019 06:00 | 2.54 | 2.62 | +3.3% | Beat |
| 07 Feb 2019 06:00 | 2.49 | 2.52 | +1.2% | Beat |
| 24 Oct 2018 06:00 | 2.89 | 2.74 | -5.1% | Miss |
| 25 Jul 2018 06:00 | 2.92 | 2.98 | +1.9% | Beat |
| 25 Apr 2018 07:00 | 2.63 | 2.78 | +5.7% | Beat |
| 06 Feb 2018 06:00 | 2.38 | 2.45 | +3.1% | Beat |
| 25 Oct 2017 06:00 | 2.39 | 2.46 | +3.1% | Beat |
| 26 Jul 2017 06:00 | 2.41 | 2.47 | +2.7% | Beat |
| 25 Apr 2017 06:00 | 2.20 | 2.22 | +1.1% | Beat |
| 16 Feb 2017 06:00 | 2.13 | 2.15 | +0.9% | In line |
| 26 Oct 2016 06:00 | 2.29 | 2.25 | -1.8% | Miss |
| 27 Jul 2016 06:00 | 2.30 | 2.31 | +0.6% | In line |
| 25 Apr 2016 06:00 | 1.96 | 2.02 | +3.1% | Beat |
| 18 Feb 2016 06:00 | 2.00 | 1.98 | -1.0% | Miss |
| 26 Oct 2015 06:00 | 2.06 | 2.07 | +0.3% | In line |
| 28 Jul 2015 07:00 | 2.03 | 2.09 | +2.8% | Beat |
| 27 Apr 2015 06:00 | 1.63 | 1.73 | +6.3% | Beat |
| 20 Feb 2015 07:00 | 1.64 | 1.65 | +0.9% | In line |
| 28 Oct 2014 06:00 | 1.75 | 1.80 | +2.9% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 14B | +7.2% | 876.5M | 6.3% | 10.46 | +18.3% | 1.2B |
| 2024 | 13B | +7.0% | 746M | 5.7% | 8.84 | +85.3% | 1.1B |
| 2023 | 12.2B | +2.5% | 418M | 3.4% | 4.77 | -65.9% | 874.1M |
| 2022 | 11.9B | — | 1.3B | 10.8% | 13.97 | — | 1.5B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 09 Nov 2026 – 12 Nov 2026 In progress | 369.28 | 375.10 | 363.19 | 372.32 | +1.57% | 2,569,300 | |
| 02 Nov 2026 – 06 Nov 2026 | 361.54 | 373.34 | 350.66 | 366.57 | +1.43% | 4,002,200 | |
| 26 Oct 2026 – 30 Oct 2026 | 329.77 | 371.00 | 326.32 | 361.39 | +9.86% | 5,168,100 | |
| 19 Oct 2026 – 23 Oct 2026 | 316.54 | 331.71 | 314.69 | 328.95 | +3.46% | 3,434,600 | |
| 12 Oct 2026 – 16 Oct 2026 | 310.11 | 327.50 | 310.11 | 317.95 | +1.86% | 2,680,700 | |
| 05 Oct 2026 – 09 Oct 2026 | 308.08 | 318.18 | 304.92 | 312.15 | +1.19% | 3,551,900 | |
| 28 Sep 2026 – 02 Oct 2026 | 306.85 | 312.57 | 302.71 | 308.49 | -0.37% | 3,181,400 | |
| 21 Sep 2026 – 25 Sep 2026 | 321.95 | 323.84 | 303.13 | 309.64 | -3.45% | 4,915,200 | |
| 14 Sep 2026 – 18 Sep 2026 | 314.12 | 327.95 | 308.21 | 320.71 | +2.94% | 4,445,300 | |
| 08 Sep 2026 – 11 Sep 2026 | 321.18 | 328.07 | 305.45 | 311.54 | -4.70% | 3,646,200 | |
| 252 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Labcorp Holdings Inc. (LH) Presents at 2026 UBS Global Healthcare Conference Transcript (opens in a new tab) SeekingAlpha · 11 Nov 2026 01:30
- Is Now the Right Time to Hold Labcorp Stock in Your Portfolio? (opens in a new tab) Zacks · 10 Nov 2026 17:57
- Here’s Why Wall Street Still Sees Room in Labcorp (LH) Even After Its Run (opens in a new tab) Insider Monkey · 09 Nov 2026 18:47
- Labcorp completes $375M Millennium Health takeover (opens in a new tab) MedTech Dive · 09 Nov 2026 18:00
- Global Cardiovascular Genetic Testing Market Report 2026 | Capitalize on 11% CAGR and AI Genomics with Labcorp, Quest Diagnostics, Illumina, and Fulgent Genetics (opens in a new tab) 09 Nov 2026 14:08
- Labcorp to Speak at the UBS Global Healthcare Conference (opens in a new tab) 04 Nov 2026 13:00
- Labcorp’s Q3 earnings call: our top 5 analyst questions (opens in a new tab) StockStory · 02 Nov 2026 21:17
- Labcorp (LH) Stock Fair Value Edges Higher After Q3 Analyst Revisions (opens in a new tab) Simply Wall St. · 30 Oct 2026 06:14
- Labcorp Holdings (LH) Expands HPV Testing While Teaming With Regulators On Drug Safety (opens in a new tab) Simply Wall St. · 29 Oct 2026 20:09
- Labcorp (LH) Stock Shrugs Off Q3 Earnings As PAMA Risk Looms (opens in a new tab) Simply Wall St. · 29 Oct 2026 18:12
- Labcorp (LH) stock trades up, here is why (opens in a new tab) StockStory · 29 Oct 2026 01:58
- Stock Market Today: Dow, Nasdaq Rise After No Fed Rate Hike; Labcorp Blasts Off (opens in a new tab) Investor's Business Daily · 28 Oct 2026 20:59
- Labcorp: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 28 Oct 2026 18:37
- Labcorp (LH) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 28 Oct 2026 17:58
- LH Stock Hits Record Levels, CHE Stock Surges To Over 52-Week Highs – Here’s What’s Driving Investor Enthusiasm (opens in a new tab) Stocktwits · 28 Oct 2026 17:56
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 372.23 USD
- Market cap
- 30.2B
- Dividend yield
- 0.77%
- 5-year average yield
- 0.96%
- Payout ratio
- 24%
- Last dividend
- 0.7200 USD · 24 Nov 2026
- Next ex-dividend date
- 24 Nov 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 28 Aug 2026 | 0.7200 USD |
| 29 May 2026 | 0.7200 USD |
| 27 Feb 2026 | 0.7200 USD |
| 26 Nov 2025 | 0.7200 USD |
| 8 older dividends: create a free account to see them | |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 3.2 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 21.5 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 5.4 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 7.1 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 6.3 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 2.5 / 5 |
|
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 30.52× | Weak | 30.56× |
| P/E (forward) | 19× | Fair | 14.16× |
| Price / book | 3.42× | Weak | 3.5× |
| Price / sales | 2.07× | Fair | 3.33× |
| EV / EBITDA | 15.71× | Weak | 11.19× |
| Free cash flow yield | 3.5% | Fair | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 29% | Fair | 54.9% |
| Operating margin | 11.2% | Fair | 5.8% |
| Net margin | 6.9% | Fair | 1.2% |
| Return on equity | 11.4% | Fair | 4.4% |
| Return on assets | 5.5% | Fair | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 5.6% | Fair | 10.1% |
| EPS growth / year | -9.2% | Weak | 10.2% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.77× | Good | 0.4× |
| Net debt / EBITDA | 2.81× | Fair | 1.46× |
| Interest cover | 6.77× | Fair | 2.17× |
| Current ratio | 1.41× | Fair | 2.64× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 23.6% | Good | 0% |
| Payout of free cash flow | 22.8% | Good | 28.7% |
| Payout of free cash flow (3 years) | 23.2% | Good | — |
| Dividend growth / year | 5.8% | Good | 6.5% |
| Years of rising dividends | 0 | Weak | 1.5 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow LH and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.